riparin (cas 112356-54-4) II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms
-
Add time:07/26/2019 Source:sciencedirect.com
riparin (cas 112356-54-4) II (RIP II) is an alkamide isolated from Aniba riparia that has presented antidepressant and anxiolytic effects in acute stress behavioral models. This study aimed to investigate the activity of RIP II in a corticosterone-induced depression mice model. Corticosterone (20 mg/kg, s.c.) was administered once a day for 21 days. RIP II (50 mg/kg, p.o.) or fluvoxamine (FLU, 50 mg/kg, standard antidepressant, p.o.) was administered after corticosterone (CORT) injection, for the last 7 days of CORT treatment. Mice were exposed to the following behavioral tests: forced swimming, tail suspension, open field, sucrose preference, elevated plus maze and ymaze. After behavioral evaluation, brain areas (prefrontal cortex, hippocampus and striatum) were dissected for neurochemical evaluation: oxidative stress parameters (MDA, nitrite and GSH) and BDNF dosage. Repeated CORT administration caused depressive-like behavior in mice as indicated by increased despair effects in forced swimming and tail suspension tests and anhedonia in sucrose preference test. In addition, CORT decreased BDNF levels in the mice hippocampus and induced oxidative load in the brain with significative increase in pro-oxidant markers (lipid peroxidation and nitrite levels) and a decline in anti-oxidant defense system (reduced glutathione levels), indicating a direct effect of stress hormones in the induction of the brain oxidative stress. On the other hand, RIP II treatment reversed CORT-induced depressive-like behavior. Furthermore, this treatment reversed the impairment in BDNF levels and oxidative brain insults caused by CORT. This may demonstrate the mechanisms involved in antidepressant-like effect of RIP II. These findings further support that RIP II may be implicated as pharmacological intervention targeting depression associated with HPA-axis dysregulation.
We also recommend Trading Suppliers and Manufacturers of riparin (cas 112356-54-4). Pls Click Website Link as below: cas 112356-54-4 suppliers
Prev:riparin (cas 112356-54-4) A, a compound from Aniba riparia, attenuate the inflammatory response by modulation of neutrophil migration
Next:Evaluation of the anti-inflammatory activity of riparin (cas 112356-54-4) II (O-methil-N-2-hidroxi-benzoyl tyramine) in animal models) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Blood matrix effects for male and female Wistar rats, in simultaneous HPLC-UV determination of riparin (cas 112356-54-4) I and III from Aniba riparia (Nees) Mez. (Lauraceae)07/28/2019
- Evaluation of the anti-inflammatory activity of riparin (cas 112356-54-4) II (O-methil-N-2-hidroxi-benzoyl tyramine) in animal models07/27/2019
- riparin (cas 112356-54-4) A, a compound from Aniba riparia, attenuate the inflammatory response by modulation of neutrophil migration07/25/2019
- Antinociceptive activity of riparin (cas 112356-54-4) II from Aniba riparia: Further elucidation of the possible mechanisms07/24/2019
- Pathophysiological investigations, anxiolytic effects and interaction of a semisynthetic riparin (cas 112356-54-4) with benzodiazepine receptors07/23/2019
- Synthesis, characterization and cytotoxic evaluation of inclusion complexes between riparin (cas 112356-54-4) A and β-cyclodextrin07/22/2019
- Spectral and computational features of the binding between riparin (cas 112356-54-4)s and human serum albumin07/20/2019
- Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin (cas 112356-54-4) derivatives07/21/2019
- Reversal effect of riparin (cas 112356-54-4) IV in depression and anxiety caused by corticosterone chronic administration in mice07/19/2019


